BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10964266)

  • 1. Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole.
    Gouillon Z; Lucas D; Li J; Hagbjork AL; French BA; Fu P; Fang C; Ingelman-Sundberg M; Donohue TM; French SW
    Proc Soc Exp Biol Med; 2000 Sep; 224(4):302-8. PubMed ID: 10964266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CYP2E1 in the pathogenesis of alcoholic liver disease: modifications by cAMP and ubiquitin-proteasome pathway.
    Gouillon ZQ; Miyamoto K; Donohue TM; Wan YJ; French BA; Nagao Y; Fu P; Reitz RC; Hagbjork A; Yap C; Yuan QX; Ingelman-Sundberg M; French SW
    Front Biosci; 1999 Sep; 4():A16-25. PubMed ID: 10477671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dilinoleoylphosphatidylcholine decreases ethanol-induced cytochrome P4502E1.
    Aleynik MK; Lieber CS
    Biochem Biophys Res Commun; 2001 Nov; 288(4):1047-51. PubMed ID: 11689017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite the induction of CYP2E1.
    Koop DR; Klopfenstein B; Iimuro Y; Thurman RG
    Mol Pharmacol; 1997 Jun; 51(6):944-50. PubMed ID: 9187260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zonated expression of cytokines in rat liver: effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlormethiazole.
    Fang C; Lindros KO; Badger TM; Ronis MJ; Ingelman-Sundberg M
    Hepatology; 1998 May; 27(5):1304-10. PubMed ID: 9581684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans.
    Gebhardt AC; Lucas D; Ménez JF; Seitz HK
    Hepatology; 1997 Oct; 26(4):957-61. PubMed ID: 9328319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
    Eap CB; Schnyder C; Besson J; Savary L; Buclin T
    Clin Pharmacol Ther; 1998 Jul; 64(1):52-7. PubMed ID: 9695719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidase activities of the multicatalytic protease in rat liver after voluntary and intragastric ethanol administration.
    Donohue TM; Zetterman RK; Zhang-Gouillon ZQ; French SW
    Hepatology; 1998 Aug; 28(2):486-91. PubMed ID: 9696015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors.
    Morimoto M; Hagbjörk AL; Wan YJ; Fu PC; Clot P; Albano E; Ingelman-Sundberg M; French SW
    Hepatology; 1995 Jun; 21(6):1610-7. PubMed ID: 7768506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic ethanol administration on rat liver proteasome activities: relationship with oxidative stress.
    Fataccioli V; Andraud E; Gentil M; French SW; Rouach H
    Hepatology; 1999 Jan; 29(1):14-20. PubMed ID: 9862843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1.
    Liu C; Russell RM; Seitz HK; Wang XD
    Gastroenterology; 2001 Jan; 120(1):179-89. PubMed ID: 11208727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome inhibitor up regulates liver antioxidative enzymes in rat model of alcoholic liver disease.
    Bardag-Gorce F; Oliva J; Lin A; Li J; French BA; French SW
    Exp Mol Pathol; 2011 Feb; 90(1):123-30. PubMed ID: 21036165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cytochrome P4502E1 by chlormethiazole attenuated acute ethanol-induced fatty liver.
    Chen YY; Zhang CL; Zhao XL; Xie KQ; Zeng T
    Chem Biol Interact; 2014 Oct; 222():18-26. PubMed ID: 25162931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice.
    Lu Y; Zhuge J; Wang X; Bai J; Cederbaum AI
    Hepatology; 2008 May; 47(5):1483-94. PubMed ID: 18393316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity.
    Cederbaum AI
    Dig Dis; 2010; 28(6):802-11. PubMed ID: 21525766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation to chronic ethanol administration emphasized by fatty acid hydroxylations in rat liver and kidney microsomes.
    Amet Y; Plée-Gautier E; Berthou F; Adas F; French SW
    Eur J Nutr; 2000 Dec; 39(6):270-6. PubMed ID: 11395987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A voluntary oral-feeding rat model for pathological alcoholic liver injury.
    Tipoe GL; Liong EC; Leung TM; Nanji AA
    Methods Mol Biol; 2008; 447():11-31. PubMed ID: 18369908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Time- and NADPH-Dependent Inhibition of Human CYP2E1 by Clomethiazole.
    Stresser DM; Perloff ES; Mason AK; Blanchard AP; Dehal SS; Creegan TP; Singh R; Gangl ET
    Drug Metab Dispos; 2016 Aug; 44(8):1424-30. PubMed ID: 27149898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol.
    Bardag-Gorce F; Yuan QX; Li J; French BA; Fang C; Ingelman-Sundberg M; French SW
    Biochem Biophys Res Commun; 2000 Dec; 279(1):23-9. PubMed ID: 11112412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice.
    Lu Y; Wu D; Wang X; Ward SC; Cederbaum AI
    Free Radic Biol Med; 2010 Nov; 49(9):1406-16. PubMed ID: 20692331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.